摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(E)-4-methoxy-6-(4-methoxystyryl)-5,6-dihydro-2H-pyran-2-one | 3328-60-7

中文名称
——
中文别名
——
英文名称
(E)-4-methoxy-6-(4-methoxystyryl)-5,6-dihydro-2H-pyran-2-one
英文别名
(E)-6-(4-methoxystyryl)-4-methoxy-5,6-dihydropyran-2-one;5,6-dihydroyangonin;4-methoxy-2-[(E)-2-(4-methoxyphenyl)ethenyl]-2,3-dihydropyran-6-one
(E)-4-methoxy-6-(4-methoxystyryl)-5,6-dihydro-2H-pyran-2-one化学式
CAS
3328-60-7
化学式
C15H16O4
mdl
——
分子量
260.29
InChiKey
AYXCIWVJOBQVFH-VMPITWQZSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    119-122°C
  • 溶解度:
    可溶于氯仿(少许)、甲醇(少许)

计算性质

  • 辛醇/水分配系数(LogP):
    2.5
  • 重原子数:
    19
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.27
  • 拓扑面积:
    44.8
  • 氢给体数:
    0
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    参考文献:
    名称:
    Heck-Matsuda 芳基化作为获取从远志、Piper methysticum 和类似物中分离的 Kavalactones 的策略
    摘要:
    在此,我们使用 Heck 描述了从远志(即 1、4 和 7)中分离的三种生物活性吡喃酮和从 Piper methysticum 中分离出的 8 种(即 8-10、13、15 和 18-20)的全合成– 松田芳基化作为关键策略。通过使用不同的芳烃重氮四氟硼酸盐对该方法的评估表明,当进行芳基化的烯烃具有乙烯基-2-吡喃酮结构单元而不是乙烯基二氢-2-吡喃酮部分时,Heck 芳基化更有效。许多被测烯烃的 Heck-Matsuda 芳基化反应以实用的方式进行,具有完全的区域和立体控制。
    DOI:
    10.1002/ejoc.201200308
  • 作为产物:
    描述:
    potassium carbonate 作用下, 以 甲醇丙酮 为溶剂, 反应 3.0h, 生成 (E)-4-methoxy-6-(4-methoxystyryl)-5,6-dihydro-2H-pyran-2-one
    参考文献:
    名称:
    A rapid and diverse construction of 6-substituted-5,6-dihydro-4-hydroxy-2-pyrones through double Reformatsky reaction
    摘要:
    A rapid and diverse synthesis of biologically important 6-substituted-5,6-dihydro-4-hydroxy-2-pyrones through a double Reformatsky reaction of aldehydes to delta-hydroxy-beta-ketoesters followed by lactonization is described. Due to the high functional group tolerance and reaction site discrimination between aldehyde, nitrile, and ester groups in the substrate, the protocol can provide the dihydropyrones with bromo, nitro, carboxylic acid, and beta-ketoester groups, which are suitable for the further derivatizations. Furthermore, the protocol has been successfully applied to the rapid total synthesis of naturally occurring Yangonin. (C) 2013 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tet.2013.10.079
点击查看最新优质反应信息

文献信息

  • Highly Regio- and Stereoselective Heck Reaction of Allylic Esters with Arenediazonium Salts: Application to the Synthesis of Kavalactones
    作者:Angélica Venturini Moro、Flávio Sega Pereira Cardoso、Carlos Roque Duarte Correia
    DOI:10.1021/ol901416e
    日期:2009.8.20
    highly efficient palladium-catalyzed Heck reaction of allylic esters with arenediazonium salts is described. The reaction proceeds under mild conditions, with excellent to total regio- and stereochemical control and with retention of the traditional leaving group. Furthermore, the generality of the present methodology is illustrated by the short total synthesis of the natural kavalactones, yangonine,
    描述了烯丙基酯与槟榔重氮盐的高效钯催化的Heck反应。反应在温和的条件下进行,对区域和立体化学的控制极好,并且保留了传统的离去基团。此外,本方法的一般性通过天然的kavalactones,仰光宁,(±)-甲基美替丁素和(±)-二氢甲基美替丁素的短的全合成来说明。
  • Towards synthesis of kavalactone derivatives
    作者:Patrícia A. Amaral、Nicolas Gouault、Myriam Le Roch、Vera L. Eifler-Lima、Michèle David
    DOI:10.1016/j.tetlet.2008.07.102
    日期:2008.11
    Kavalactone derivatives were synthesized using a Heck reaction of the 4-methoxy-6-vinyl-5,6-dihydropyran-2-one with aryl iodides. The Suzuki-Miyaura reaction of an aryl boronic acid and (Z)-4-methoxy-6-(2-iodovinyl)-5,6-dihydropyran-2-one has also been successfully used to produce both Z and E isomers of lactones. (C) 2009 Elsevier Ltd. All rights reserved.
  • THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF
    申请人:KUALITY HERBCEUTICS LLC
    公开号:US20180134679A1
    公开(公告)日:2018-05-17
    The invention provides compounds that are useful for treating or preventing cancer.
  • [EN] THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF<br/>[FR] COMPOSÉS THÉRAPEUTIQUES ET LEURS MÉTHODES UTILISATION
    申请人:KUALITY HERBCEUTICS LLC
    公开号:WO2016179587A1
    公开(公告)日:2016-11-10
    The invention provides compounds that are useful for treating or preventing cancer.
  • A rapid and diverse construction of 6-substituted-5,6-dihydro-4-hydroxy-2-pyrones through double Reformatsky reaction
    作者:Masahiro Mineno、Yasuhiro Sawai、Kazuaki Kanno、Naotaka Sawada、Hideya Mizufune
    DOI:10.1016/j.tet.2013.10.079
    日期:2013.12
    A rapid and diverse synthesis of biologically important 6-substituted-5,6-dihydro-4-hydroxy-2-pyrones through a double Reformatsky reaction of aldehydes to delta-hydroxy-beta-ketoesters followed by lactonization is described. Due to the high functional group tolerance and reaction site discrimination between aldehyde, nitrile, and ester groups in the substrate, the protocol can provide the dihydropyrones with bromo, nitro, carboxylic acid, and beta-ketoester groups, which are suitable for the further derivatizations. Furthermore, the protocol has been successfully applied to the rapid total synthesis of naturally occurring Yangonin. (C) 2013 Elsevier Ltd. All rights reserved.
查看更多

同类化合物

(4-甲氧基-6-[(E)-2-(3-甲氧基苯基)乙烯基]-5,6-二氢-2H-吡 麻醉椒苫素 麻醉椒苦素 醉椒素 甲氧醉椒素 去甲氧基醉椒素 二氢麻醉椒素 二氢醉椒素 二氢醉人素 S(-)-α-甲基苄胺 N-[(1S)-1-(4-甲氧基-6-氧代吡喃-2-基)-2-苯基乙基]乙酰胺 6-[2-(4-羟基苯基)乙烯基]-4-甲氧基吡喃-2-酮 6-[2-(4-羟基苯基)乙烯基]-4-甲氧基吡喃-2-酮 5,6-去氢醉椒素 4-甲氧基-6-[2-(4-甲氧基苯基)乙基]吡喃-2-酮 4-甲氧基-6-(2-苯基乙烯基)-2H-吡喃-2-酮 4-甲氧基-6-(2-苯基乙基)吡喃-2-酮 (5S,6S)-5-乙酰氧基-5,6-二氢-4,6-二甲氧基-6-[(E)-2-苯乙烯基]-2H-吡喃-2-酮 (E)-4-methoxy-6-(2-methoxystyryl)-2H-pyran-2-one 4-methoxy-6-(4-nitrostyryl)-2H-pyran-2-one 6-(4-fluorostyryl)-4-methoxy-2H-pyran-2-one (E)-4-methoxy-6-(4-propylstyryl)-2H-pyran-2-one 6-[(E)-2-(4-chlorophenyl)vinyl]-4-methoxy-2H-pyran-2-one 4-methoxy-6-(p-nitro-trans-styryl)-2H-pyran-2-one (E)-4-methoxy-6-(2-methylstyryl)-2H-pyran-2-one (E)-4-methoxy-6-(3-methylstyryl)-2H-pyran-2-one (E)-6-(4-ethoxystyryl)-4-methoxy-2H-pyran-2-one (S)-4-Ethoxy-6-phenethyl-5,6-dihydro-pyran-2-one 6-[(Z)-2-(3,4-dimethoxyphenyl)ethenyl]-4-methoxy-2H-pyran-2-one 2H-Pyran-2-one, 6-[2-(3,4-dimethoxyphenyl)ethyl]-5,6-dihydro-4-methoxy-, (S)- 2H-Pyran-2-one, 5,6-dihydro-6-[2-(3-hydroxy-4-methoxyphenyl)ethyl]-4-methoxy-, (S)- 4-acetoxy-6-<(E)-2-phenylethenyl>-2H-pyran-2-one Kavain (Z)-6-(4-methoxystyryl)-4-methoxy-5,6-dihydropyran-2-one 7,8-dihydromethysticin aspernigrin B (R)-Methysticin 6,6'-(1E,1'E)-2,2'-(1,4-phenylene)bis(ethene-2,1-diyl)bis(4-methoxy-2H-pyran-2-one) 4-methoxy-6-[2-(1-naphthyl)ethyl]-2H-pyran-2-one 4-methoxy-6-(3',4'-dihydroxystyryl)-2-pyrone 4-methoxy-6-[2-(4-tert-butylphenyl)ethyl]-2H-pyran-2-one 6,6'-(2,2'-(1,4-phenylene)bis(ethane-2,1-diyl))bis(4-methoxy-2H-pyran-2-one) 4-methoxy-6-(3,4,5-trimethoxyphenethyl)-2H-pyran-2-one 6-(3,4-dimethoxyphenethyl)-4-methoxy-2H-pyran-2-one 4-methoxy-6-[2-(2-naphthyl)ethyl]-2H-pyran-2-one (E)-4-methoxy-6-(3,4,5-trimethoxystyryl)-2H-pyran-2-one 4-methoxy-6-[2-(3-(4-tert-butylphenoxy)phenyl)ethyl]-2H-pyran-2-one O-Methyl-hispidin 4-methoxy-6-(3-nitrostyryl)-2H-pyran-2-one (E)-6-(4-(dimethylamino)styryl)-4-methoxy-2H-pyran-2-one